Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2025 11:26 ET | Source: Research and Markets

Direct Oral Anticoagulants (DOACs) Market Projected to Reach $49.88 Billion by 2030 - Surge in Cardiovascular Disease Prevalence and Drug Innovations Fuels Growth

Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Direct Oral Anticoagulants (DOACs) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
January 24, 2024 10:32 ET | Source: Research and Markets

Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...
April 25, 2012 13:00 ET | Source: American Heart Association

Stroke Risk High When Anti-Clotting Drugs Stopped

Study Highlights: Patients with irregular heartbeats who take anti-clotting medications are at high risk of stroke or blood clot whenever the drugs are stopped. The risks are similar...
September 08, 2011 18:26 ET | Source: American Heart Association

AHA Perspective on FDA Committee Decision on Rivaroxaban

DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...